Summary
The aim of this study was to examine the influence of inhibition on angiotensin converting enzyme (ACE) of myocardial function and perfusion of the rat impaired by diabetes. Spontaneously diabetic rats were treated with the ACE-inhibitor captopril for 4 months. Cardiac performance was analysed in the isolated heart perfused at constant volume. Epicardial perfusion was determined by measuring changes in epicardial fluorescence after injection of a bolus of fluoresceinisothiocyanate-dextrane (3 kDa) as described previously. As compared to untreated diabetic controls, captopril prevented the increase of end diastolic pressure, coronary perfusion pressure and vascular resistance. The intravascular volume was enlarged and the epicardial perfusion rate increased in hearts of diabetic rats treated with captopril as compared to diabetic controls. Treatment of diabetic rats with the ACE-inhibitor captopril (1) increases the number of perfused capillaries, and (2) can partly prevent the development of cardiac dysfunction in diabetes. Together with morphological data demonstrating an inhibition of interstitial and perivascular fibrosis in hearts of diabetic rats treated with captopril, our data suggest that ACE-inhibition is cardioprotective in diabetes. These observations are also compatible with the assumption that an accelerated generation of angiotensin II may be involved in the pathophysiological chain of events leading to diabetic cardiopathy.
Article PDF
Similar content being viewed by others
Abbreviations
- ACE:
-
Angiotensin converting enzyme
- CVR:
-
coronary vascular resistance
- EDP:
-
end diastolic pressure
- LVP:
-
left ventricular pressure
- CPP:
-
coronary perfusion pressure
References
Kannel WB, McGee FL (1979) Diabetes and cardiovascular disease: the Framingham study. JAMA 241: 2035–2038
Palumbo PJ, Elveback CR, Conolly DC (1981) Coronary artery disease and congestive heart failure in the diabetic: epidemiological aspects: The Rochester Project. In: Scott RC (ed) Clinical cardiology and diabetes, pp 13–34
Uusitupa MIJ, Mustonen JN, Airaksinen KE (1990) Diabetic heart muscle disease. Ann Med 22: 377–386
Rösen P, Pogatsa G, Tschöpe D, Addicks K, Reinauer H (1992) Diabetische Kardiopathie: Pathophysiologische Konzepte und therapeutische AnsÄtze. Klin Wochenschr. 69: 3–15
Zoneraich S (1988) Small vessel disease, coronary vasodilation reserve, and diabetic microangiopathy. Chest 94: 5–7
Cannon RO, Cunnion RE, Parillo JE et al. (1987) Dynamic limitation of coronary vasodilator reserve in patients with dilated cardio-myopathy and chest pain. J Am Coll Cardiol 10: 1190–1200
Fein FS, Sonnenblick EH (1985) Diabetic cardiomyopathy. Prog Cardiovasc Dis 27: 255–270
Rösen P, Windeck P, Zimmer HG, Frenzel H, Burrig KF, Reinauer H (1986) Myocardial performance and metabolism in non-ketotic, diabetic rat hearts: myocardial function and metabolism in vivo and in the isolated perfused heart under the influence of insulin and octanoate. Basic Res Cardiol 81: 620–635
Rösen P, Kiesel U, Reinauer H, Boy C, Addicks K (1991) Cardiopathy in the spontaneously diabetic (BB)rat: evidence for microangiopathy and autonomic neuropathy in the diabetic heart.In: Nagano M, Dhalla NS (eds) The diabetic heart. Kluver Press, New York, pp 145–157
Rodrigues B, McNeill JH (1992) The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovasc Res 26: 913–922
Bhimji S, Godin DV, McNeill JH (1986) Insulin reversal of biochemical changes in hearts from diabetic rats. Am J Physiol 251: H670-H675
Regan TJ, Lyons MM, Ahmed SS (1977) Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 60: 885–889
Hamby RI, Zoneraich S, Shermann L (1974) Diabetic cardiomyopathy. JAMA 229: 1749–1754
Shapiro LM (1985) Diabetes-induced heart muscle disease and left ventricular dysfunction. Practical Cardiol 11: 79–91
Koltai MZ, Rösen P, Hadhazy P, Ballagi-Pordany G, Koszeghy A, Pogatsa G (1988) Effects of hypoxia and adrenergic stimulation induced alterations in PGI2 synthesis by diabetic coronary arteries. J Diabetic Complications 2: 5–7
Tahiliani AG, McNeill JH (1986) Diabetes-induced abnormalities in the myocardium. Life Sci 38: 959–974
Rösen P, Rösen R, Hohl C, Reinauer H, Klaus W (1984) Reduced transcoronary exchange and prostaglandin synthesis in diabetes rat heart. Am J Physiol 247: H563-H569
Addicks K, Boy C, Rösen P (1993) Sympathetic autonomic neuropathy in the heart of the spontaneous diabetic BB rat. Annals of Anatomy — Anatomischer Anzeiger 175: 253–257
Regan TJ, Ettinger PO, Khan MI et al. (1974) Altered myocardial function and metabolism in chronic diabetes mellitus without ischemia in dogs. Circ Res 35: 222–237
Pierce GN, Dhalla NS (1985) Mechanisms of the defect in cardiac myofibrillar function during diabetes. Am J Physiol 248: E170-E175
Dominiak P (1993) Modulation of sympathetic control by ACE inhibitors. Eur Heart J 14: 169–172
Meisel AS, Phillips C, Michel MC, Ziegler MG, Carter SM (1989) Regulation of cardiac Β-adrenergic receptors by captopril. Circ 80: 669–675
Lindpaitner K, Ganten D (1991) The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence. Circ Res 68: 905–921
Dostal DE, Baker KM (1993) Evidence for a role of an intracardic renin-angiotensin system in normal and failing heart. TCM 3: 67–74
Weber K, Brilla CG (1991) Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circ 83: 1849–1865
Dietz R, Haberbosch W, Osterziel KJ, Förderer T, Busch C (1992) Kardioreparative Effekte der ACE-Hemmer. Klin Wochenschr 69 [Suppl] (XXIX): 16–24
Clozel M, Kuhn H, Hefti F, Baumgartner HR (1991). Endothelial dysfunction and sub-endothelial monocyte macrophages in hypertension. Effect of angiotensin enzyme inhibition. Hypertension 18: 132–141
Rösen P, Eckel J, Reinauer H (1983) Influence of bradykinin on glucose uptake and metabolism studied in isolated cardiac myocytes and isolated perfused rat hearts. J Biol Chem 364: 1431–1438
Rett K, Jauch KW, Wicklmayr M, Dietze G, Fink E, Mehnert H (1986) Angiotensin converting enzyme inhibitors in diabetes: experimental and human experience. Postgrad Med J 62: 59–64
Jauch KW, Hartl W, Guenther B, Rett K, Dietze G (1987) Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin dependent diabetes mellitus. Eur J Clin Invest 17: 448–457
Cushman DW, Cheung HS (1971) Spectrophotometric assay and properties of the angiotensin converting enzyme of rabbit lung. Biochem Pharmacol 20: 1637–1648
Rösen R, Beck E, Rösen P (1988) Early vascular alterations in the diabetic heart. Acta Physiol Hun'g 72: 3–11
Hartmann JF, Szemplinski M, Hayes NS, Keegan ME, Slater EE (1988) Effects of the angiotensin enzyme inhibitor, lisinopril, on normal and diabetic rats. J Hypertension 6: 677–683
Valentovic M, Elliott C (1986) Angiotensin converting enzyme activity as function of the duration of the streptozotocin (STZ)-induced diabetes. Fed Proc 45: 463
Toop M, Dallinger K, Jennings P, Barnett A (1986) Angiotensin converting enzyme (ACE): relationship to insulin-dependent diabetes and microangiopathy. Diabet Med 3: 455–457
Boy C, Rösen P, Bloch W, Hess A, Happich D, Addicks K (1993) Diabetic cardiopathy in the spontaneous diabetic BB rat is diminished by long term application of the angiotensin converting enzyme inhibitor captopril. Proc 3rd Int Symp on ACE (in press)
Raya TE, Gay RG, Aguirre M, Goldman S (1989) Importance of venodilation in the prevention of left ventricular dilatation after chronic large myocardial infarction in rats: a comparison of captopril and hydralazine. Circ Res 64: 330–337
Jackson CV, McGrath GM, Tahiliani AG, Vadlamudi RV, McNeill JH (1985) A functional and ultrastructural analysis of experimental diabetic rat myocardium. Manifestation of a cardiomyopathy. Diabetes 34: 876–883
McDowell TS, Chapleau MW, Hajduzcok G, Abboud FM (1994). Baroreflex dysfunction in diabetes mellitus. I. Selective impairment of parasympathetic control of heart rate. Am J Physiol 266: H235-H243
McDowell TS, Chapleau MW, Hajduzcok G, Abboud PM (1994). Baroreflex dysfunction in diabetes mellitus. II. Site of baroreflex impairment in diabetic rabbits. Am J Physiol 266: H244-H249
Fein FS, Miller-Green B, Sonnenblick EH (1985) Altered myocardial mechanics in diabetic rabbits. Am J Physiol 248: H729-H736
Ward WF, Molteni A, Tsao Ch, Hinz JM (1990) Captopril reduces collagen and mast cell accumulation in irradiated rat lung. Int J Radiation Oncol 19: 1405–1409
Lindpaitner K, Jim MW, Niedermaier N, Wilhelm MJ, Ganten D (1990) Cardiac angiotensinogen and its local activation in the isolated perfused beating heart. Circ Res 67: 564–573
Yamaji T, Fakuhara T, Kinoshita M (1993) Increased capillary permeability to albumin in diabetic rat myocardium. Circ Res 72: 947–957
Wiemer G, Schölkens BA, Becker RHA, Busse R (1991) Ramiprilat enhances endothelial autocoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension 18: 558–563
Raya TE, Lee RW, Westhoff T, Goldman S (1989) Captopril restores hemodynamic responsiveness to atrial natriuretic peptide in rats with heart failure. Circ 80: 1886–1892
Baker KM (1991) Cardiac actions of angiotensin. J Vasc Med Biol 3: 30–37
Peach MJ (1977) Renin-angiotensin systems: biochemistry and mechanisms of action. Physiol Rev 57: 317–370
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rösen, R., Rump, A.F.E. & Rösen, P. The ACE-inhibitor captopril improves myocardial perfusion in spontaneously diabetic (BB) rats. Diabetologia 38, 509–517 (1995). https://doi.org/10.1007/BF00400718
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400718